surgery of penile and urethral carcinoma
DESCRIPTION
Surgery of Penile and Urethral Carcinoma. Campbell’s Urology Chapter 32 W. Britt Zimmerman April 15, 2009. Surgery of Penile & Urethral Carcinoma. Penile Cancer Male Urethral Cancer Female Urethral Cancer. Penile Cancer. Typically Squamous Involves: Glans penis Coronal Sulcus - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/1.jpg)
Surgery of Penile andUrethral Carcinoma
Campbell’s Urology Chapter 32
W. Britt Zimmerman
April 15, 2009
![Page 2: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/2.jpg)
Surgery of Penile & Urethral Carcinoma
• Penile Cancer
• Male Urethral Cancer
• Female Urethral Cancer
![Page 3: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/3.jpg)
Penile Cancer
• Typically Squamous
• Involves:– Glans penis– Coronal Sulcus– Inner preputial skin
![Page 4: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/4.jpg)
Penile Cancer
• Biopsy– Imperative to include area of question as well as
adjacent normal tissue• Allows for evaluation of depth of invasion
– May be punch or excisional
– Urethral meatus involvement• Urethroscopy is mandatory
![Page 5: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/5.jpg)
Penile Cancer
• Laser Therapy– Carbon Dioxide (CO2)
– Neodymium:yttrium-aluminum-garnet (Nd:YAG)– Potassium titanyl phosphate (KTP)
– Circumcision is usually recommended at the time of laser surgery if not already done
![Page 6: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/6.jpg)
Laser Therapy
• CO2
– Wavelength: 10,600 nm– Skin depth: 0.01 mm– Blood vessels: 0.5 mm– 33% local recurrence– Healing time: 5 – 8 weeks
![Page 7: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/7.jpg)
Laser Therapy
• Nd:YAG– Most commonly reported– Skin dept: 3 – 6 mm– 20% recurrence
• Stage T1
– Healing time: 8 – 12 weeks
• Combination– Surgery and laser to the base
18% – 20% recurrence
![Page 8: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/8.jpg)
Laser Therapy
• KTP– Wavelength: 532 nm– Intermediate depth
• Between CO2 and Nd:YAG
– Healing time: 8 – 12 weeks
![Page 9: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/9.jpg)
Laser Therapy
• Technical improvements– 5% Acetic acid wraps– 5-aminolevulinic acid
• Final thoughts– Reasonable for Tis and T1 SCC– T2 patients refusing aggressive surgery
![Page 10: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/10.jpg)
Mohs Micrographic Surgery
• Excision of penile cancer by thin tissue layers
• Frozen sectioning with immediate pathological evaluation
• Cure rates (5 years)– < 1 cm: 100%– 1 – 2 cm: 83%– 2- 3 cm: 75%– > 3 cm: 50%
![Page 11: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/11.jpg)
Mohs Micrographic Surgery
• Best suited for small superficial cancers
• Comparable to partial penectomy– In the right setting
![Page 12: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/12.jpg)
Conservative Surgical Excision
Local excision and Glansectomy
• In the setting of low stage penile cancer
• Traditionally, 2 cm margin
• Grade plays a central role– Grade 1 & 2
• Histologic extent 5 mm
• Location also plays a role– Coronal Sulcus 50% recurrence
![Page 13: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/13.jpg)
Conservative Surgical Excision
• Glanular tumors– Difficult secondary inability to achieve adequate
margin
– Preputial skin flap or split thickness skin graft (STSG) can assist in closure
– Recurrence:• Traditionally 32 – 40%• Contemporary studies 8 – 11%
![Page 14: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/14.jpg)
Figure 32-1 Surgical glans defect covered with outer preputial flap as described by Ubrig and colleagues (2001). A, Superficial glans tumor. B, Outer preputial flap outlined. C, Tumor excised and circumcision performed. D, Glans defect filled with outer preputial flap.
![Page 15: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/15.jpg)
Figure 32-2 Finely meshed extragenital split-thickness skin graft quilted to glans defect after superficial tumor excision.
![Page 16: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/16.jpg)
Conservative Surgical Excision
• Total Glansectomy– First described in 1996– Used in patients with stage T1 & T2 SCC of the glans,
prepuce, and coronal sulcus– Dissassembly of glans and distal corpus spongiosum
• Frozen section for margin evaluation• STSG with urethrostomy formation
– Benefits• Voiding• Sexual function preservation
![Page 17: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/17.jpg)
Partial Penectomy
• Most common surgical procedure for treatment of patients primary SCC
• Penile amputation– 2 cm proximal to the tumor– Goals
• Voiding• Sexual function
![Page 18: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/18.jpg)
Partial Penectomy
Figure 32-3 Partial penectomy. A, Incision with ligation and division of dorsal penile vessels within Buck's fascia (inset). B,
Corpora transected and urethra spatulated. C and D, Closure of corpora cavernosa. E,
Final closure with construction of urethrostomy.
![Page 19: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/19.jpg)
Partial Penectomy
• 1.0 to 1.5 cm distal to the cavernosal amputation site
• Urethrostomy is created by approximating the urethra to the surrounding penile skin
• Lengthening– Suspensory ligament division
![Page 20: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/20.jpg)
Partial Penectomy
• Skin coverage– Scrotal flaps– Z-plasty
• Glans reconstruction– Skin grafts– Pedicle flaps
![Page 21: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/21.jpg)
Penectomy
• Local recurrence rates– 0 – 8%
![Page 22: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/22.jpg)
Total Penectomy
• At the level of the suspensory ligament– Corpra cavernosa proximally remains
• Performed for large or proximal Lesions
• Patients void sitting down via a perineal urethrostomy
![Page 23: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/23.jpg)
Total Penectomy
Figure 32-5 Total penectomy. A, Incision. B, Transection of the corpora
near the level of the pubis. C, Mobilization of the remaining urethra off of the proximal corporal bodies. D, Transposition of the urethra through a
curvilinear perineal incision. E, Completion of perineal urethrostomy.
![Page 24: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/24.jpg)
Perineal Urethrostomy
![Page 25: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/25.jpg)
Perineal Urethrostomy
![Page 26: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/26.jpg)
Perineal Urethrostomy
![Page 27: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/27.jpg)
Perineal Urethrostomy
Foley left for 7 – 10 days
![Page 28: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/28.jpg)
Radical Penectomy
• The corporal bodies are dissected to the tips of the crura, which are completely excised.
• Urethra is matured into a standard perineal urethrostomy.
![Page 29: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/29.jpg)
Radical Penectomy
![Page 30: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/30.jpg)
Regional Lymph Nodes
• SCC on the penis spreads regionally before it spreads distantly.– No skip lesions.
• One midline structure can metastasize to either side or bilaterally.
• Metastatic lymph nodes confer a poorer prognosis– Aggressive lymphadenectomy: cure in 30 – 60%
![Page 31: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/31.jpg)
Inguinal Anatomy
• Lymph nodes– Superficial– Deep
• Superficial lymph nodes (5 groups)– Central (saphenofemoral junction)– Superolateral (superficial circumflex vein)– Inferolateral (lateral femoral & superficial circumflex)– Superomedial (superficial ext. pudendal & superficial
epigastric veins– Inferomedial (greater saphenous vein)
![Page 32: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/32.jpg)
Superficial lymph nodes (5 groups)
Figure 32-14 Superficial inguinal lymph nodes and the branches of the saphenous vein. SEV, superficial epigastric; SEPV, superficial external pudendal; MCV, medial cutaneous; LCV, lateral cutaneous; SCIV, superficial circumflex iliac.
![Page 33: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/33.jpg)
Inguinal Anatomy
• Deep inguinal nodes– Medial to femoral vein in the femoral canal– Cloquet – most cephalad of the deep group
• Between the femoral vein and the lacunar ligament
– External iliac nodes• Deep inguinal• Obturator• Hypogastric
![Page 34: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/34.jpg)
Deep Inguinal Nodes
![Page 35: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/35.jpg)
Inguinal Anatomy
• Skin blood supply– Common femoral artery
• Superficial external pudendal• Superficial circumflex iliac• Superficial epigastric arteries
• Transverse skin incision compromises the least amount of blood supply
![Page 36: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/36.jpg)
Inguinal Anatomy
• Femoral nerve– Deep to iliacus fascia– Motor
• Pectineus• Quadriceps femoris• Sartorius
– Sensation• Anterior thigh
![Page 37: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/37.jpg)
Inguinal Anatomy
• Femoral triangle:– Inguinal ligament – superiorly– Sartorius muscle – laterally– Adductor longus muscle – medially
– Floor• Pectineus (medially) and iliopsoas (laterally)
![Page 38: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/38.jpg)
Sentinel Node Biopsy
• First describe by Cabanas in 1977
• Results a have been variable
![Page 39: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/39.jpg)
Modified Inguinal Lymphadenectomy
• Catalona 1988– Same therapeutic benefit– Less morbidity– Key aspects
1. Shorter skin incision
2. Excludes the area lateral to the femoral artery and caudal to the fossa ovalis
3. Saphenous vein preservation
4. Elimination of sartorius muscle transposition
![Page 40: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/40.jpg)
Modified Inguinal Lymphadenectomy
Figure 32-17 Limits of standard and modified groin dissection. (From Colberg JW, Andriole GL, Catalona WJ: Long-term follow-up of men undergoing modified
inguinal lymphadenectomy for carcinoma of the penis. Br J
Urol 1997;79:54-57.)
![Page 41: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/41.jpg)
Modified Inguinal Lymphadenectomy
Figure 32-18 Modified inguinal lymphadenectomy. Lymph node packet is medial to the femoral artery and includes superficial and deep inguinal nodes.
![Page 42: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/42.jpg)
Modified Inguinal Lymphadenectomy
Figure 32-19 Intraoperative photograph of right inguinal region after modified lymphadenectomy. SC, spermatic cord; V, femoral vein; S, saphenous vein; AL, adductor longus.
![Page 43: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/43.jpg)
Radical Ilioinguinal Lymphadenectomy
• Indicated in patients with resectable metastatic adenopathy and may be curative when inguinal nodes disease only.
• May also be used in palliation
![Page 44: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/44.jpg)
Radical Ilioinguinal Lymphadenectomy
![Page 45: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/45.jpg)
Radical Ilioinguinal Lymphadenectomy
Figure 32-21 Ilioinguinal lymph node dissection. A, Incisions for inguinofemoral lymph node dissection (1), unilateral pelvic lymph node dissection (2), and bilateral pelvic lymph node dissection (3). B, Single incision approach for ilioinguinal lymph node dissection.
![Page 46: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/46.jpg)
Radical Ilioinguinal Lymphadenectomy
Figure 32-22 A, Incision and area of dissection for left inguinofemoral lymph node dissection with excision of adherent skin overlying nodal mass. B, Single incision approach and area of dissection for right ilioinguinal lymph node dissection with excision of overlying skin.
![Page 47: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/47.jpg)
Radical Ilioinguinal Lymphadenectomy
![Page 48: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/48.jpg)
Radical Ilioinguinal Lymphadenectomy
Figure 32-25 Inferior dissection during radical inguinofemoral lymph node dissection with
removal of lymph node packet from the inferior border of the femoral triangle. After
further lateral and medial dissection, the packet will remain in continuity with the pelvic dissection in the area of the femoral canal.
![Page 49: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/49.jpg)
Radical Ilioinguinal Lymphadenectomy
Figure 32-27 Sartorius muscle after detachment from the anterior superior iliac spine and 180-degree rotation medially, with suture fixation to the fascia of the inguinal ligament and the adductor longus. S, sartorius muscle; SC, spermatic cord.
Figure 32-26 Intraoperative photograph after right radical inguinofemoral lymph node dissection in an obese patient. S, sartorius muscle; A, femoral artery; V, femoral vein; IL, inguinal ligament.
![Page 50: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/50.jpg)
Key Points of Penile Cancer
• Early meticulous surgical management with close follow-up generally provides the best opportunity for cure of penile SCC.
• Include some adjacent normal tissue with the specimen to allow optimal evaluation of the depth of invasion of the cancer during biopsy.
![Page 51: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/51.jpg)
Key Points of Penile Cancer
• Conservative surgical approaches may be reasonable for patients with stage Tis and small T1 SCC of the penis and for patients with manageable T2 tumors who refuse more aggressive surgical treatment.
• Partial penectomy with a 2-cm surgical margin remains the most common surgical procedure for treatment of the primary tumor in patients with invasive SCC and affords excellent local control in most instances.
![Page 52: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/52.jpg)
Key Points of Penile Cancer
• In patients at risk for the development of inguinal metastatic disease and with no palpable adenopathy, modified inguinal lymphadenectomy provides excellent assessment of the regional nodes and may be converted to a full lymphadenectomy if metastatic disease is detected.
• Penile cancer metastases to the pelvic lymph nodes do not occur in the setting of negative ipsilateral inguinal nodes.
![Page 53: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/53.jpg)
Male Urethral Cancer
![Page 54: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/54.jpg)
Male Urethral Carcinoma
• Rare and presents in the 5th decade of life.
• Etiology is typically secondary to chronic inflammation.– STDs– Urethritis– Urethral stricture– HPV 16
![Page 55: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/55.jpg)
Male Urethral Carcinoma
• Insidious onset
• 50% have stricture
• 25% have STD history
• 96% symptomatic– Palpable urethral mass– Obstructive voiding symptoms
![Page 56: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/56.jpg)
Male Urethral Carcinoma
![Page 57: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/57.jpg)
Pathology
• Bulbomembranous – 60%
• Penile – 30%
• Prostatic – 10%
• SCC – 80%
• TCC – 15%
• Adenocarcinoma – 5%
![Page 58: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/58.jpg)
Pathology
• Direct extension
• Lymphatic invasion
• Anterior – superficial and deep inguinal, and occasionally external iliac nodes
• Posterior – pelvic lymph nodes
• Palpable lymph nodes are present 20% of the time and usually represent metastatic disease
![Page 59: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/59.jpg)
Evaluation & StagingPrimary tumor (T) (male and female) TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary, polypoid, or verrucous carcinoma TisCarcinoma in situ T1 Tumor invades subepithelial connective tissue T2 Tumor invades any of the following: corpus spongiosum, prostate,
periurethral muscle T3 Tumor invades any of the following: corpus cavernosum, beyond prostatic
capsule, anterior vagina, bladder neck T4 Tumor invades other adjacent organs
Transitional cell carcinoma of the prostate Tis-pu Carcinoma in situ, involvement of the prostatic urethra Tis-pd Carcinoma in situ, involvement of the prostatic ducts T1 Tumor invades subepithelial connective tissue T2 Tumor invades any of the following: prostatic stroma, corpus spongiosum, periurethral muscle T3 Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, bladder neck (extraprostatic extension) T4 Tumor invades other adjacent organs (invasion of the bladder)
![Page 60: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/60.jpg)
Evaluation & Staging
Regional lymph nodes (N)NX Regional lymph nodes cannot be assessedN0 No regional lymph node metastasisN1 Metastasis in a single lymph node, 2 cm or less in greatest
dimensionN2 Metastasis in a single lymph node, more than 2 cm but less than 5
cm in greatest dimension; or in multiple nodes, none greater than 5 cmN3 Metastasis in a lymph node greater than 5 cm in greatest
dimension
Distant metastasis (M)MX Presence of distant metastasis cannot be assessedM0 No distant metastasisM1 Distant metastasis
![Page 61: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/61.jpg)
Treatment
• Primarily a surgically treated disease process
• Anterior urethral lesion is more amendable to surgical control
• Posterior disease– Associated with extensive local invasion– Distant mets
![Page 62: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/62.jpg)
Carcinoma of the Penile Urethra
• Superficial, papillary, low-grade tumors– TUR– Local excision
• Infiltrating– Lesions located to distal half of penis
• Partial penectomy with 2 cm margin
– Lesions proximal• Total penectomy
![Page 63: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/63.jpg)
Carcinoma of the Penile Urethra
![Page 64: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/64.jpg)
Carcinoma of the Penile Urethra
Prophylactic inguinal lymph node dissection (LND) offers no benefit
![Page 65: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/65.jpg)
Carcinoma of the Bulbomemebranous Urethra
• Poor survival figures for all recorded forms of treatment– Radical surgery offers best longer-term prognosis
• Radical cystoprostatectomy• Pelvic lymphadenectomy• Total penectomy• Pubic rami resection• GU diaphragm excision
![Page 66: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/66.jpg)
Carcinoma of the Bulbomemebranous Urethra
![Page 67: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/67.jpg)
Radiation Therapy & Chemotherapy
• XRT– Early-stage lesions of the anterior urethra– Preserves skin– Results are undetermined
• Chemo– MVAC good for TCC lesions– Platinum based therapy
• Results poor
• Combo therapy– XRT and Chemo– Surgery and Chemo
![Page 68: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/68.jpg)
Management of the Urethra after Cystectomy
• General Considerations– Cancer recurrence following cystoprostatectomy
• 2.1 – 11.1% recurrence (cutaneous diverison)• 0.5 – 4% recurrence (orthotopic neobladder)
• Frozen section of apical margins of prostatic urethra during surgery should be NEGATIVE.
• 40% of recurrence within 1 year– 18 months median
![Page 69: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/69.jpg)
Management of the Urethra after Cystectomy
• Traditionally urethral wash was acceptable– Survival benefit has been questioned
• Patients who have positive voided cytology or symptoms:– Urethral bleeding– Discharge– Palpable mass
• Cystoscopy and Biopsy– Superficial recurrence can be treated with BCG via urethral perfusion
![Page 70: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/70.jpg)
Total Urethrectomy after Cutaneous Diversion
• Care must be exercised in completing the proximal dissection, in view of the possible postcystectomy adherence of intestine to the superior surface of the urogenital diaphragm.
![Page 71: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/71.jpg)
Total Urethrectomy after Orthotopic Diversion
• Abdominal perineal approach
• Can use previous bowel for diversion– Careful dissection to preserve blood supply
• Commonly perform ileal conduit, but carefully selected patient may undergo a continent reservoir creation
![Page 72: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/72.jpg)
Urethrectomy after Cystoprostatectomy
![Page 73: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/73.jpg)
Key Points: Male Urethral Cancer
• 80% of male urethral cancers are SCC– Bulbomembranous urethra most common site
• Anterior urethral carcinoma– More amenable to surgical control– Better prognosis
• Posterior urethral carcinoma– Extensive local invasion– Distant metastasis
![Page 74: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/74.jpg)
Key Points: Male Urethral Cancer
• Prophylactic inguinal lymph node dissection has no benefit
• Low incidence of urethral recurrence after orthotopic bladder replacement – Negative frozen-section biopsy of the distal
prostatic urethral margin during surgery
![Page 75: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/75.jpg)
Key Points: Male Urethral Cancer
• Converting a patient to cutaneous conduit urinary diversion, bowel from the existing orthotopic neobladder can often be reconfigured with its blood supply intact and used for this purpose.
![Page 76: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/76.jpg)
Female Urethral Cancer
![Page 77: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/77.jpg)
Epidemiology, Etiology, & Clinical Presentation
• Epidemiology– more in women, 4:1– Only urological malignancy with female
predominance– 0.2% of all GU malignancies– <1% of CA of female GU tract– 85% occurs in white women ( of 1200 cases
reported)
![Page 78: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/78.jpg)
Epidemiology, Etiology, & Clinical Presentation
• Etiology– Leukoplakia, chronic irritation, caruncles, polyps,
partuition, HPV, other viral infection– Urethral diverticula
• 5% of CA – Predisposition?
![Page 79: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/79.jpg)
Epidemiology, Etiology, & Clinical Presentation
• Clinical Presentation– 98% have symptoms
• Most common obstructive• Dysuria, urethral bleeding, frequency, palpable,
urethral mass, induration• Otherwise healthy middle-aged woman with new-onset
UR?– Think urethral tumor (and neurolgic disease…..)
![Page 80: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/80.jpg)
Epidemiology, Etiology, & Clinical Presentation
• Patterns of Spread– Local
• Direct extension, may ulcerate @ skin/vulva• If proximal may extend:
– Posteriorly into vagina
– Proximally into bladder
– Lymphatic involvement:• 1/3 @ presentation (palpable nodes)• ½ of pts with advanced/proximal tumors
– Hematogenous• Lung, liver, bone, brain
![Page 81: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/81.jpg)
Anatomy & Physiology
• Anterior (distal 1/3)– Can maintain
continence with excision
• Posterior (proximal 2/3)
![Page 82: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/82.jpg)
Anatomy & Physiology
• Histology of urethra– Epithelium
• Proximal 1/3– Transitional urothelium
• Distal 2/3– Stratified squamous
– Glands• Columnar epithelium
– Lymphatics• Post urethra
– External/internal illiac, obturator• Ant urethra/ labia
– Superficial/deep inguinal
![Page 83: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/83.jpg)
Anatomy & Physiology
• Histology of Neoplasm– SCC 50-70%– TCC 10%– Adenocarcinoma 25%
• Glandular origin• Associated with diverticula
– Rare: lymphoma, neuroendocrine, sarcoma, paragangliomas, melanoma, metastasis
![Page 84: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/84.jpg)
Diagnosis & Staging
• Evaluation– Cysto, EUA, CT A/P, CXR– +/- MRI for extension
• Staging– TNM (see male)– Pelvic LN mets:
• 20%– Distant LN mets:
• 15%– Palpable nodes:
• 30% overall• Confirmed malignancy: 90%• 50% of proximal or advanced CA
![Page 85: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/85.jpg)
Treatment & Prognosis
• Prognosis– No survival difference based on histological
subtype
• Treatment– Tumor location– Clinical stage
![Page 86: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/86.jpg)
Treatment
• Local excision vs extensive surgery– Small, distal urethral tumors, superficial
• Survival facts– 5 yr DSS (disease specific survival)
• 71% (distal)• 48% (proximal)• 24% (large urethral lesions)
– Overall survival (Surgery, XRT)• 30-40% • Unchanged in 50yrs
![Page 87: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/87.jpg)
Treatment
• Options– Surgery, XRT, chemo, combo– Multimodality preferred
• Survival @ 5-6 yrs: (Early urethral CA in women, Table 32-2)– XRT (42 pts) 30%– Surgery (14 pts) 10%– Combo (3 pts) 2%
![Page 88: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/88.jpg)
Treatment
• Distal Urethral CA– Small, exophytic, superficial tumor from urethral
meatus:• Options:
– Circumferential excision of distal urethra & portion of anterior vaginal wall
– Laser coag described (small, distal tumors)– Urethrectomy & diversion
» Anterior vaginal wall, periurethral tissues to bladder neck» Ileovesicostomy, appendicovesicostomy to native bladder
![Page 89: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/89.jpg)
Treatment
• Facts, surgical data:– Distal tumor
• Low stage• Cure rate 70-90% with local excision
– 21 % with < T2 treated with partial urethrectomy had a local recurrence (Dimarco et al 2004)
– 0-50% recurrence with partial urethrectomy +/- rads (Hahn 1991, Ghelier 1998)
![Page 90: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/90.jpg)
Treatment
• Complications– Meatal stenosis– SUI (DiMarco 2004)
![Page 91: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/91.jpg)
Treatment
• Radiation– Low stage distal urethral CA– 5 yr DSS 41% (Gordon 1993)
• 74% (part of urethra involved)• 55% (entire urethra involved)
![Page 92: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/92.jpg)
Treatment
• Delivery– XRT, Brachy, Combination– Results
• Combo – Fewer failures (14%) than all radiation Rx patients (36%) & surgery
alone (60%) (University of Iowa)
– Complications• 20-40%• UI, strictures, necrosis, fistulas, cystitis, cellulitis
– Prognosis• 5 yr survival: surgery, radiation “similar” (Foens, 1991)
![Page 93: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/93.jpg)
Treatment
• Various Rx: Advanced stage urethral CA (Table 32-3)– Radiation: 25 people, 28% survival, 5-6 yrs– Surgery: 13 people, 15% survival, 5-6 yrs– XRT + Surgery: 20 people, 5% survival, 5-6 yrs– XRT+Chemo+Surg: 6 people, 50% survival, 2 yrs
![Page 94: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/94.jpg)
Treatment
• Ilioinguinal lymphadenectomy– Significant morbidity– Systemic spread without regional LN involve– No improved survival after pelvic, inguinal LADN– Can’t predict micrometastatic LN involvement– Recommend: no prophylactic or diagnostic LND– Candidates for LND
• (+) inguinal, pelvic LAD on presentation without distant mets
• Pts who develop regional LAD during surveillance
![Page 95: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/95.jpg)
Treatment
• Proximal female urethral CA– Facts
• More likely high stage• Advanced female urethral CA involves:
– Proximal location, entire urethra– Locally invasive lesion: external genitalia, vagina or bladder
• Multimodal Rx is the rule• Prognosis
– With anterior exenteration: 10-17% (5 yrs)– Local recurrence 67%
![Page 96: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/96.jpg)
Treatment
• Proximal female urethral CA– Anterior exenteration, pelvic LN dissection
(standard bladder + Cloquet’s node), wide vaginal or complete vaginal excision for (-) margins
• PRN: partial vulvectomy, labial excision• PRN: pubis resection
![Page 97: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/97.jpg)
Treatment
• Prognosis– Radiotherapy alone
• 0-57% survival (5 yrs)
– Combo (XRT + surgery)• Mean survival 54% (5 yrs)
– Chemo + XRT + surgery• Local, distant control in advanced CA
– SCC» 5 FU + Mitomycin C
– TCC» MVAC or Gemcitabine
![Page 98: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/98.jpg)
Urethral recurrence after Cystectomy in women
• Facts– Incidence of CA involving urethra in females
undergoing cystectomy for CaB 1-13%– Bladder neck involvement and urethral sparing
surgery (controversial)– Few reported cases of urethral CA despite
increasing # of orthotopic neobladders (urethral preservation)
![Page 99: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/99.jpg)
Urethral recurrence after Cystectomy in women
• Limited data No conclusive treatment Rec. – Options (in the absence of mets):
• Urethrectomy, resection of anastomosis with conversion to continent cutaneous diversion
• Conversion to cutaneous urinary conduit with bowel from orthotopic diversion
![Page 100: Surgery of Penile and Urethral Carcinoma](https://reader036.vdocuments.net/reader036/viewer/2022081520/568157c3550346895dc54a12/html5/thumbnails/100.jpg)
Surgery of Penile andUrethral Carcinoma
Campbell’s Urology Chapter 32
W. Britt Zimmerman
April 15, 2009